Poster (Scientific congresses and symposiums)
Retifanlimab (INCMGA00012) in Patients With Recurrent MSI-H or dMMR Endometrial Cancer: Results From the POD1UM-101 Study
Berton, Dominique; Pautier, Patricia; Lorusso, Domenica et al.
2021Society for Immunotherapy of Cancer's 36th Annual Meeting
 

Files


Full Text
Retifanlimab in Patients With Recurrent MSI-H or dMMR Endometrial Cancer.pdf
Publisher postprint (649.43 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Berton, Dominique
Pautier, Patricia
Lorusso, Domenica
GENNIGENS, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
Gladieff, Laurence
Kryzhanivska, Anna
Ranganathan, Sulabha
Tian, Chuan
Bourayou, Nawel
Vergote, Ignace
Language :
English
Title :
Retifanlimab (INCMGA00012) in Patients With Recurrent MSI-H or dMMR Endometrial Cancer: Results From the POD1UM-101 Study
Publication date :
10 November 2021
Event name :
Society for Immunotherapy of Cancer's 36th Annual Meeting
Event place :
Wasthington, United States - District of Columbia
Event date :
10-14 novembre 2021
Audience :
International
Available on ORBi :
since 22 November 2021

Statistics


Number of views
51 (3 by ULiège)
Number of downloads
2 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi